SCHEMBL6708935

SCHEMBL6708935

O=C(Nc1ccc(Cl)cc1-c1noc(=O)[nH]1)c1cc2cccc(NC(=O)C3CCCC3)c2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.41
PLCG2 P16885 1/20 0.39
GRM5 P41594 1/20 0.39
KMT2A Q03164 2/20 0.37
PLA2G7 Q13093 1/20 0.36
GRM4 Q14833 1/20 0.36
NR2E3 Q9Y5X4 1/20 0.36
KDM4E B2RXH2 2/20 0.36
NPC1 O15118 1/20 0.36
CYP1A2 P05177 1/20 0.36
MAOB P27338 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
PYGL P06737 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PTK2B Q14289 1/20 0.35
MDM2 Q00987 1/20 0.35
NHERF1 O14745 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708773 0.99 GRIK1 (0.41) GRIK1PLCG2GRM5KMT2APLA2G7
SCHEMBL6711491 0.98 GRIK1 (0.41) GRIK1PLCG2GRM5KMT2APLA2G7
SCHEMBL6707685 0.97 GRIK1 (0.42) GRIK1PLCG2KMT2APLA2G7NPC1
SCHEMBL6710073 0.91 GRIK1 (0.39) GRIK1PLCG2PLA2G7NPC1RAB9A
SCHEMBL6709354 0.90 GPR35 (0.40) GRIK1KMT2AKDM4ENPC1CYP1A2
SCHEMBL6712074 0.89 GPR35 (0.41) GRIK1KMT2AKDM4ENPC1CYP1A2
SCHEMBL6707967 0.89 GRIK1 (0.39) GRIK1PLCG2PLA2G7MAOBPYGL
SCHEMBL6707972 0.89 GRIK1 (0.39) GRIK1PLCG2PLA2G7MAOBPYGL
SCHEMBL6707970 0.89 GRIK1 (0.39) GRIK1PLCG2PLA2G7MAOBPYGL
SCHEMBL6707746 0.89 GRIK1 (0.39) GRIK1KDM4ENPC1CYP1A2MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885PLCG2 4289/4885GRM5 4139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.